Terry J. Rosen - Dec 15, 2024 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Chief Executive Officer, Director
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Stock symbol
RCUS
Transactions as of
Dec 15, 2024
Transactions value $
-$609,143
Form type
4
Date filed
12/17/2024, 08:36 PM
Previous filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Tax liability -$609K -37.9K -1.57% $16.08 2.37M Dec 15, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
F2 This amount reflects 1,547,062 shares of the Issuer's Common Stock that are no longer beneficial owned by the Reporting Person as a result of him entering into a "domestic relations order", which change in beneficial ownership is exempt from Section 16 pursuant to Rule 16a-12 under the Securities Exchange Act of 1934, as amended.